T1	Outcomes 575 597	maximum tolerated dose
T2	Outcomes 660 670	toxicities
T3	Outcomes 751 773	tumor marker responses
T4	Outcomes 787 797	DCP levels
T5	Outcomes 839 850	AFP levels.
T6	Outcomes 887 890	PRs
T7	Outcomes 900 913	stable tumors
T8	Outcomes 928 946	tumor progression.
T9	Outcomes 996 1060	phosphorylation of JNK and c-Jun and caspase-mediated apoptosis.
